Sol Carriazo

1.3k total citations
18 papers, 306 citations indexed

About

Sol Carriazo is a scholar working on Nephrology, Molecular Biology and Genetics. According to data from OpenAlex, Sol Carriazo has authored 18 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 6 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Sol Carriazo's work include Renal and related cancers (4 papers), Genetic Syndromes and Imprinting (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). Sol Carriazo is often cited by papers focused on Renal and related cancers (4 papers), Genetic Syndromes and Imprinting (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). Sol Carriazo collaborates with scholars based in Spain, United States and Canada. Sol Carriazo's co-authors include Alberto Ortíz, María Dolores Sánchez-Niño, Beatriz Fernández‐Fernández, Ana B. Sanz, Elena Gomá-Garcés, María José Soler, Adrián M. Ramos, Jorge Rojas-Rivera, María Vanessa Pérez-Gómez and Raúl Fernández-Prado and has published in prestigious journals such as International Journal of Molecular Sciences, Kidney International and Nutrients.

In The Last Decade

Sol Carriazo

17 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sol Carriazo Spain 11 117 69 58 50 49 18 306
JH Barth United Kingdom 9 68 0.6× 57 0.8× 87 1.5× 23 0.5× 38 0.8× 19 334
Belde Kasap Demir Türkiye 9 64 0.5× 73 1.1× 36 0.6× 43 0.9× 18 0.4× 68 298
Natalia Campos‐Obando Netherlands 11 103 0.9× 49 0.7× 18 0.3× 42 0.8× 51 1.0× 15 316
Despina Kyriaki Greece 10 83 0.7× 24 0.3× 39 0.7× 39 0.8× 40 0.8× 24 329
Raiz Ahmad Misgar India 12 68 0.6× 116 1.7× 216 3.7× 94 1.9× 34 0.7× 35 427
Florian G. Scurt Germany 9 88 0.8× 76 1.1× 49 0.8× 80 1.6× 25 0.5× 32 360
Vittoria Esposito Italy 12 113 1.0× 79 1.1× 12 0.2× 41 0.8× 56 1.1× 27 332
Vladimir Dobronravov Russia 8 182 1.6× 64 0.9× 27 0.5× 32 0.6× 18 0.4× 87 333
Fouad Fadel France 7 78 0.7× 39 0.6× 61 1.1× 62 1.2× 20 0.4× 12 274
Mallory L. Downie Canada 8 116 1.0× 70 1.0× 24 0.4× 56 1.1× 14 0.3× 22 259

Countries citing papers authored by Sol Carriazo

Since Specialization
Citations

This map shows the geographic impact of Sol Carriazo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sol Carriazo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sol Carriazo more than expected).

Fields of papers citing papers by Sol Carriazo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sol Carriazo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sol Carriazo. The network helps show where Sol Carriazo may publish in the future.

Co-authorship network of co-authors of Sol Carriazo

This figure shows the co-authorship network connecting the top 25 collaborators of Sol Carriazo. A scholar is included among the top collaborators of Sol Carriazo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sol Carriazo. Sol Carriazo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Carriazo, Sol & York Pei. (2025). Do Overweight Status and Obesity Affect Progression to ESKD in Autosomal Dominant Polycystic Kidney Disease?. Clinical Journal of the American Society of Nephrology. 20(4). 471–473. 1 indexed citations
2.
Garimella, Pranav S., et al.. (2025). Cardiovascular Complications in ADPKD. Kidney International Reports. 10(9). 2953–2966.
3.
Valiño‐Rivas, Lara, Aránzazu Pintor‐Chocano, Sol Carriazo, et al.. (2024). Loss of NLRP6 increases the severity of kidney fibrosis. Journal of Cellular Physiology. 239(9). e31347–e31347. 1 indexed citations
4.
Sánchez-Niño, María Dolores, Sol Carriazo, Aránzazu Pintor‐Chocano, et al.. (2023). Interaction of Fabry Disease and Diabetes Mellitus: Suboptimal Recruitment of Kidney Protective Factors. International Journal of Molecular Sciences. 24(21). 15853–15853. 3 indexed citations
5.
Krishnan, Anoushka, et al.. (2023). Approach to Pregnancy in Patients With Lupus Nephritis. Kidney Medicine. 5(11). 100724–100724. 4 indexed citations
6.
Carriazo, Sol, et al.. (2023). Increased expression of SCARF genes favoring SARS-CoV-2 infection in key target organs in CKD. Clinical Kidney Journal. 16(12). 2672–2682. 1 indexed citations
7.
Fernández-Prado, Raúl, Beatriz Fernández‐Fernández, Catalina Martín-Cleary, et al.. (2023). Sodium zirconium cyclosilicate and metabolic acidosis: Potential mechanisms and clinical consequences. Biomedicine & Pharmacotherapy. 158. 114197–114197. 8 indexed citations
8.
Cuarental, Leticia, Aránzazu Pintor‐Chocano, Sol Carriazo, et al.. (2022). The transcription factor Fosl1 preserves Klotho expression and protects from acute kidney injury. Kidney International. 103(4). 686–701. 23 indexed citations
9.
Carriazo, Sol, et al.. (2022). Tirzepatide and prevention of chronic kidney disease. Clinical Kidney Journal. 16(5). 797–808. 43 indexed citations
10.
Carriazo, Sol, et al.. (2021). Increased 1-year mortality in haemodialysis patients with COVID-19: a prospective, observational study. Clinical Kidney Journal. 15(3). 432–441. 22 indexed citations
11.
Carriazo, Sol, et al.. (2021). Aguascalientes: one of the hottest chronic kidney disease (CKD) hotspots in Mexico and a CKD of unknown aetiology mystery to be solved. Clinical Kidney Journal. 14(11). 2285–2294. 15 indexed citations
12.
Favero, Chiara, Sol Carriazo, Leticia Cuarental, et al.. (2021). Phosphate, Microbiota and CKD. Nutrients. 13(4). 1273–1273. 25 indexed citations
13.
Carriazo, Sol, Adrián M. Ramos, Ana B. Sanz, et al.. (2020). Chronodisruption: A Poorly Recognized Feature of CKD. Toxins. 12(3). 151–151. 26 indexed citations
14.
Fernández‐Fernández, Beatriz, Ignacio Mahíllo, Jinny Sánchez-Rodríguez, et al.. (2020). Gender, Albuminuria and Chronic Kidney Disease Progression in Treated Diabetic Kidney Disease. Journal of Clinical Medicine. 9(6). 1611–1611. 18 indexed citations
15.
Martínez‐Moreno, Julio M., Miguel Fontecha‐Barriuso, Diego Martín‐Sánchez, et al.. (2020). Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease. International Journal of Molecular Sciences. 21(11). 4113–4113. 52 indexed citations
16.
Esteras, Raquel, Esmeralda Castillo-Rodríguez, Sol Carriazo, et al.. (2019). Reactions to Synthetic Membranes Dialyzers: Is there an Increase in Incidence?. Kidney & Blood Pressure Research. 44(5). 907–914. 16 indexed citations
17.
Carriazo, Sol, María Vanessa Pérez-Gómez, Miguel A. García-González, et al.. (2019). Dietary Care for ADPKD Patients: Current Status and Future Directions. Nutrients. 11(7). 1576–1576. 22 indexed citations
18.
Rojas-Rivera, Jorge, Sol Carriazo, & Alberto Ortíz. (2019). Treatment of idiopathic membranous nephropathy in adults: KDIGO 2012, cyclophosphamide and cyclosporine A are out, rituximab is the new normal. Clinical Kidney Journal. 12(5). 629–638. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026